On the other hand, the imbalance between osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) levels in CKD patients increases osteoclastogenesis and induces high turnover bone disease [28,29]. Here, TNFRSF11B is linked to chronic kidney disease.